{"id":371592,"date":"2026-07-04T05:08:00","date_gmt":"2026-07-04T12:08:00","guid":{"rendered":"https:\/\/cms-articles.softonic.io\/en\/?p=371592"},"modified":"2026-07-04T05:08:16","modified_gmt":"2026-07-04T12:08:16","slug":"anthropic-launches-ai-drug-discovery-project-neglected-diseases-first","status":"publish","type":"post","link":"https:\/\/cms-articles.softonic.io\/en\/anthropic-launches-ai-drug-discovery-project-neglected-diseases-first\/","title":{"rendered":"Anthropic launches AI drug discovery project: neglected diseases first"},"content":{"rendered":"

Anthropic launched its drug discovery program today. It\u2019s a clear move into neglected-disease research, and it also introduces Claude Science, the company\u2019s workbench for genomics, proteomics, and single-cell analysis.<\/p>\n

\r\n
\r\n
\r\n
\r\n \"Claude\"\r\n <\/div>\r\n
\r\n Claude<\/span>\r\n Download<\/a>\r\n <\/div>\r\n
\r\n <\/path><\/path><\/text><\/svg>\r\n <\/div>\r\n <\/div>\r\n
\r\n <\/span>\r\n <\/div>\r\n
\r\n \r\n <\/div>\r\n <\/a>\r\n <\/div>\r\n<\/div>\n\n\n\n

The company is moving past selling tools to labs and into preclinical discovery<\/strong> itself. Anthropic\u2019s argument is that this stage fits AI unusually well: biology data is abundant, simulation and ranking can happen quickly, and failures cost less here than they do later in the process. If that plays out, early medicine development could speed up, and the work could feed back into better life-sciences products.<\/p>\n\n

There\u2019s a different business model here too. Anthropic says its public benefit corporation structure gives it room to put patients\u2019 needs ahead of short-term returns. That comes at a moment when Novartis CEO Vas Narasimhan has said these tools could cut timelines<\/strong> from about 12 years to 7 or 8, while pushing success rates from roughly 8% to 16%. Anthropic also says Claude Science connects to more than 60 databases. In its early examples, a University of California, San Francisco researcher spotted viral contamination in minutes after it had been missed for a year, and another analysis covered 100 rare genetic diseases in under an hour and surfaced 32 follow-up candidates.<\/p>\n\n

If you follow AI in biotech, this deserves a close look. Discovery is still only the first part. Clinical trials<\/a><\/strong> cost come after that.<\/p>\n\n

You can get Claude Science through Anthropic\u2019s research offering, and Anthropic\u2019s new drug program is starting with preclinical work.<\/p>","protected":false},"excerpt":{"rendered":"

Anthropic launched its drug discovery program today. It\u2019s a clear move into neglected-disease research, and it also introduces Claude Science, the company\u2019s workbench for genomics, proteomics, and single-cell analysis. The company is moving past selling tools to labs and into preclinical discovery itself. Anthropic\u2019s argument is that this stage fits AI unusually well: biology data … Continue reading “Anthropic launches AI drug discovery project: neglected diseases first”<\/span><\/a><\/p>\n","protected":false},"author":9332,"featured_media":371591,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","wpcf-pageviews":0},"categories":[1015],"tags":[],"usertag":[],"vertical":[],"content-category":[6771],"class_list":["post-371592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","content-category-ai"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/posts\/371592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/users\/9332"}],"replies":[{"embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/comments?post=371592"}],"version-history":[{"count":1,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/posts\/371592\/revisions"}],"predecessor-version":[{"id":371593,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/posts\/371592\/revisions\/371593"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/media\/371591"}],"wp:attachment":[{"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/media?parent=371592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/categories?post=371592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/tags?post=371592"},{"taxonomy":"usertag","embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/usertag?post=371592"},{"taxonomy":"vertical","embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/vertical?post=371592"},{"taxonomy":"content-category","embeddable":true,"href":"https:\/\/cms-articles.softonic.io\/en\/wp-json\/wp\/v2\/content-category?post=371592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}